CC chemokine receptor 5 genotype and susceptibility to transmission of human immunodeficiency virus type 1 in women

Journal of Infectious Diseases

Volumn 187, Issue 4, 2003, Pages 569-575

  Philpott, Sean ^a   Weiser, Barbara ^a,b   Tarwater, Patrick ^e   Vermund, Sten H ^g   Kleeberger, Cynthia A ^e   Gange, Stephen J ^e   Anastos, Kathryn ^d   Cohen, Mardge ^h   Greenblatt, Ruth M ⁱ   Kovacs, Andrea ^j   Minkoff, Howard ^c   Young, Mary A ^k   Miotti, Paolo ^f   Dupuis, Michelle ^a   Chen, Chih Hsiung ^a   Burger, Harold ^a,b  

^a WADSWORTH CENTER   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

^d MONTEFIORE MEDICAL CENTER   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^h Jr Hospital of Cook County   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j LAC USC MEDICAL CENTER   (United States)

^k GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

AFRICA; ARTICLE; ASIAN; BEHAVIOR; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROSEXUALITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RESISTANCE; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SEROEPIDEMIOLOGY; SOCIAL ASPECT; VIRUS TRANSMISSION;

COHORT STUDIES; DISEASE TRANSMISSION, HORIZONTAL; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; RECEPTORS, CCR5; UNITED STATES; URBAN POPULATION;

EID: 0037443108     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/367995     Document Type: Article

References (38)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization. The report on global HIV/AIDS epidemic: "The Barcelona Report." Geneva: UNAIDS, 2002.
2. Berger EA, Doms RW, Fenyo EM, et al. A new classification for HIV-1. Nature 1998; 391:240.
3. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996; 86:367-77.
4. Martinson JJ, Chapman NH, Rees DC, Liu YT, Clegg JB. Global distribution of the CCR5 gene 32-base pair deletion. Nat Genet 1997; 16:100-3.
5. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996; 382:722-5.
6. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996; 273:1856-62.
7. Huang Y, Paxton WA, Wolinsky SM, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996; 2:1240-3.
8. Michael NL, Chang G, Louie LG, et al. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nat Med 1997; 3:338-40.
9. Marmor M, Sheppard HW, Donnell D, et al. Homozygous and heterozygous CCR5-Δ32 genotypes are associated with resistance to HIV infection. J Acquir Immune Defic Syndr 2001; 27:472-81.
10. Hoffman TL, MacGregor RR, Burger H, Mick R, Doms RW, Collman RG. CCR5 genotypes in sexually active couples discordant for human immunodeficiency virus type 1 infection status. J Infect Dis 1997; 176:1093-6.
11. O'Brien TR, Padian NS, Hodge T, Goedert JJ, O'Brien SJ, Carrington M. CCR-5 genotype and sexual transmission of HIV-1. AIDS 1998; 12:444-5.
12. Lockett SF, Alonso A, Wyld R, et al. Effect of chemokine receptor mutations on heterosexual human immunodeficiency virus transmission. J Infect Dis 1999; 180:614-21.
13. Sullivan AD, Wigginton J, Kirschner D. The coreceptor mutation CCR5Δ32 influences the dynamics of HIV epidemics and is selected for by HIV. Proc Natl Acad Sci USA 2001; 98:10214-9.
14. Long EM, Martin HL Jr, Kreiss JK, et al. Gender differences in HIV-1 diversity at time of infection. Nat Med 2000; 6:71-5.
15. Anastos K, Gange SJ, Lau B, et al. Association of race and gender with HIV-1 RNA levels and immunologic progression. J Acquir Immune Defic Syndr 2000; 24:218-26.
16. Farzadegan H, Hoover DR, Astemborski J, et al. Sex differences in HIV-1 viral load and progression to AIDS. Lancet 1998; 352:1510-4.
17. Sterling TR, Lyles CM, Vlahov D, Astemborski J, Margolick JB, Quinn TC. Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among seroconverters. J Infect Dis 1999; 180:666-72.
18. Fideli US, Allen SA, Musonda R, et al. Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Res Hum Retroviruses 2001; 17:901-10.
19. Barkan SE, Melnick SL, Preston-Martin S, et al. Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology 1998; 9:117-25 and WIHS dossier. WDMAC, May 2001.
20. Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet 2001; 357:1397-401.
21. Strathdee SA, Galai N, Safaiean M, et al. Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Arch Intern Med 2001; 161:1281-8.
22. Centers for Disease Control and Prevention. 1993 Revised system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992; 41:1-19.
23. Hessol NA, Schwarcz S, Ameli N, Oliver G, Greenblatt RM. Accuracy of self-reports of acquired immunodeficiency syndrome and acquired immunodeficiency syndrome-related conditions in women. Am J Epidemiol 2001; 153:1128-33.
24. Philpott S, Burger H, Charbonneau T, et al. CCR5 genotype and resistance to vertical transmission of HIV-1. J Acquir Immune Defic Syndr 1999; 21:189-93.
25. Downer MV, Hodge T, Smith DK, et al. Regional variation in CCR5-Δ32 gene distribution among women from the US HIV Epidemiology Research Study (HERS). Genes Immun 2002; 3:295-8.
26. Kaslow RA, Carrington M, Apple R, et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 1996; 2:405-11.
27. Tang J, Costello C, Keet IP, et al. HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 1999; 15:317-24.
28. Allen SJ, Karita E, N'Gandu N, Tichaek A. The evolution of voluntary testing and counseling as an HIV prevention strategy. In: Preventing HIV infection in developing countries. New York: Kluwer Academic/Plenum Publishing, 1999:87-108.
29. Hoover DR, Munoz A, Carey V, et al. The unseen sample in cohort studies: estimation of its size and effect. Multicenter AIDS Cohort Study. Stat Med 1991; 10:1993-2003.
30. Gray RH, Wawer MJ, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001; 357:1149-53.
31. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342:921-9.
32. Katzenstein TL, Eugen-Olsen J, Hofmann B, et al. HIV-infected individuals with the CCRΔ32/CCR5 genotype have lower HIV RNA levels and higher CD4 cell counts in the early years of the infection than do patients with the wild type. Copenhagen AIDS Cohort Study Group. J Acquir Immune Defic Syndr 1997; 16:10-4.
33. D'Aquila RT, Sutton L, Savara A, Hughes MD, Johnson VA. CCR5/Δccr5 heterozygosity: a selective pressure for the syncytium-inducing human immunodeficiency virus type 1 phenotype. NIAID AIDS Clinical Trials Group Protocol 241 Virology Team. J Infect Dis 1998; 177:1549-53.
34. Zhang L, He T, Talal A, Wang G, Frankel SS, Ho DD. In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5. J Virol 1998; 72:5035-45.
35. + Th1 phenotype. J Immunol 1999; 163:2306-13.
36. Patterson BK, Landay A, Andersson J, et al. Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission. Am J Pathol 1998; 153:481-90.
37. Centers for Disease Control and Prevention (CDC). US HIV and AIDS cases reported through June 2001. HIV/AIDS Surveill Rep 2001; 13:18-41.
38. US Census Bureau. Quick facts web site for the year 2000 census, United States. Available at: http://quickfacts.census.gov./qfd/states/00000.html. Accessed 24 September 2002.